This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Ray Finlay & Mark Anderton

Mark Anderton is a discovery toxicologist who works within project teams to influence chemical design from a safety perspective. His colleague, Ray Finlay is a medicinal chemist in the oncology iMed. His role is to design compounds in the discovery “design-make-test-analyse” cycle

You are viewing: All posts Reset filters

Our Other Authors